The Centers for Medicare & Medicaid Services today finalized a new Center for Medicare and Medicaid Innovation payment model aimed at transforming kidney care to ensure patients with chronic kidney disease have access to high quality, coordinated care.

The End-Stage Renal Disease Treatment Choices model will be mandatory for dialysis facilities and managing clinicians in certain areas of the country beginning Jan. 1, and test whether greater use of home dialysis and kidney transplantation for Medicare beneficiaries with ESRD reduce expenditures while preserving or enhancing quality of care.

The model’s payment adjustments will begin in January and run through June 30, 2027.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Friday delayed, from May 15 to Dec. 15, the effective date for its final rule codifying how it defines “…
Headline
The Centers for Medicare & Medicaid Services yesterday released guidance on how states can receive a 10-percentage-point increase in their federal…
Headline
The Centers for Disease Control and Prevention and Health Resources and Services Administration should disaggregate and analyze maternal health data for rural…
Blog
A recent report from the Lown Institute that ranks hospitals on what they deem to be unnecessary hospital services, tests and procedures attempts to make…
Headline
Effective immediately, Medicare will pay $750 to administer monoclonal antibodies to COVID-19 patients in their residence or temporary lodging and increase…
Headline
As a rural provider, Sioux Falls, S.D.-based Avera Behavioral Health sees a high rate of suicide and drug overdoses. To help manage these cases, Avera created…